Mission
Team
Science
Pipeline
Partners
News
Contact
- Open roles

4th September 2024

Interleukin-2 | The Promise of IL-2 Therapy

Location: Paris France

Dates: September 4-7, 2024

Egle is a clinical-stage biotechnology company advancing breakthrough therapies designed to modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases.

CONTACT

Fill out this field

Please enter a valid email address.

Select an option

Fill out this field

EGLE THERAPEUTICS SAS

5 Rue Gardenat Lapostol
92150 Suresnes, France
+33-186640857
contact@egle-tx.com

© 2025

This website uses cookies to improve your experience. If you continue to use this site, you agree with it.